Consistent with these reports, expression of the pro-apoptotic genes, CASP3, CASP8 and CASP10, was increased in docetaxel-treated cancer cells under both normoxic and hypoxic conditions, but not in paclitaxel-treated cancer cells under hypoxic conditions (Fig. S2). This evidence concerns the gene CASP3 and cancer.